Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multidrug-Resistant Bacterial Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01859923
What this trial is testing

A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)

Who this might be right for
Multidrug Resistant Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Not applicableStudy completedNCT02175849
What this trial is testing

Intensifying Multi-Drug Resistant Tuberculosis Contact Tracing by Social Network Analysis

Who this might be right for
Tuberculosis Infection
Oxford University Clinical Research Unit, Vietnam 596
Not applicableStudy completedNCT04239326
What this trial is testing

Clinical Evaluation of tNGS for Diagnosis of DR-TB

Who this might be right for
Tuberculosis, Multidrug-Resistant
Foundation for Innovative New Diagnostics, Switzerland 800
Not applicableUnknownNCT02245347
What this trial is testing

Genome Sequencing of Multidrug Resistant Tuberculosis (MDR TB) in Sputum

Who this might be right for
Tuberculosis
St George's Healthcare NHS Trust 50
Not applicableStudy completedNCT02758236
What this trial is testing

Tuberculosis Research of INA-RESPOND On Drug Resistance

Who this might be right for
Lung TuberculosisMDR TB
Ina-Respond 490
Testing effectiveness (Phase 2)Study completedNCT05007821
What this trial is testing

Linezolid Dosing Strategies in Drug-Resistant TB

Who this might be right for
Tuberculosis, Multidrug-ResistantTuberculosisTuberculosis, Pulmonary
National Institute of Allergy and Infectious Diseases (NIAID) 138
Not applicableNot Yet RecruitingNCT06700577
What this trial is testing

Multidrug Resistance in Newly Diagnosed TB Patient

Who this might be right for
Tuberculosis
Assiut University 100
Not applicableUnknownNCT00676754
What this trial is testing

Epidemiology of MDR-TB in Peru

Who this might be right for
TB Multi-drug Resistant
Harvard University Faculty of Medicine 18,544
Large-scale testing (Phase 3)Study completedNCT02142751
What this trial is testing

Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli

Who this might be right for
Infection Due to ESBL Escherichia Coli
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 161
Large-scale testing (Phase 3)Ended earlyNCT01055145
What this trial is testing

Comparison of the Effect Between Levofloxacin and Moxifloxacin Among MDR-TB Patients

Who this might be right for
TB
Seoul National University Hospital 182
Large-scale testing (Phase 3)Study completedNCT00513396
What this trial is testing

High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant Tuberculosis

Who this might be right for
Tuberculosis, Multidrug-Resistant
GSVM Medical College 134
Not applicableStudy completedNCT03822156
What this trial is testing

Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort

Who this might be right for
TuberculosisTuberculosis, PulmonaryCavity+5 more
University of Ulsan 500
Not applicableAvailableNCT03786900
What this trial is testing

Fecal Microbiota Transplantation (FMT): PRIM-DJ2727

Who this might be right for
Recurrent Clostridium Difficile InfectionMultidrug-resistant Klebsiella Pneumoniae Urinary Tract Infection
Herbert DuPont, MD
Testing effectiveness (Phase 2)Active Not RecruitingNCT03828201
What this trial is testing

Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

Who this might be right for
Tuberculosis, Multidrug-Resistant
Boston University 271
Not applicableStudy completedNCT00000796
What this trial is testing

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 525
Not applicableStudy completedNCT03767374
What this trial is testing

Risk-factors for Multidrug-resistant Bacteria Colonization Among Patients at High Risk of STIs

Who this might be right for
Bacterial InfectionsHIV Infections
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 2,186
Not applicableLooking for participantsNCT05671718
What this trial is testing

Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment

Who this might be right for
Drug Resistant Tuberculosis
Johns Hopkins University 2,944
Post-approval studies (Phase 4)Study completedNCT03087890
What this trial is testing

Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria

Who this might be right for
HIV-1-infectionPneumocystis PneumoniaOpportunistic Infections+2 more
University of Bergen 537
Early research (Phase 1)UnknownNCT03575299
What this trial is testing

Clinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT Cells

Who this might be right for
Multi-drug Resistant Tuberculosis
Zhinan Yin, Ph.D. 45
Not applicableStudy completedNCT03303963
What this trial is testing

DIAgnostics for Multidrug Resistant Tuberculosis in Africa

Who this might be right for
Tuberculosis, Multidrug-Resistant
Dissou AFFOLABI 3,356
Next Page